# Hillman Solutions Corp.: financial statements, quarterly

HLMN · Nasdaq · CIK 1822492 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 26

Pages: [Overview](/companies/hlmn.md) · [Financials](/companies/hlmn/financials.md) · [Filings](/companies/hlmn/filings.md) · [Insiders](/companies/hlmn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hlmn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [399](/filings/0001822492-24-000164.md) | [348 d](/filings/0001822492-26-000019.md) | [350](/filings/0001822492-25-000095.md) | [379](/filings/0001822492-25-000172.md) | [393](/filings/0001822492-25-000202.md) | [350 d](/filings/0001822492-26-000019.md) | [359](/filings/0001822492-26-000084.md) | [403](/filings/0001822492-26-000137.md) | [425](/filings/0001822492-25-000202.md) | [365 d](/filings/0001822492-26-000019.md) | [370](/filings/0001822492-26-000084.md) | [442](/filings/0001822492-26-000137.md) |
| Selling, general and administrative | $m | [113](/filings/0001822492-24-000164.md) | [116 d](/filings/0001822492-26-000019.md) | [119](/filings/0001822492-25-000095.md) | [121](/filings/0001822492-25-000172.md) | [130](/filings/0001822492-25-000202.md) | [119 d](/filings/0001822492-26-000019.md) | [119](/filings/0001822492-26-000084.md) | [124](/filings/0001822492-26-000137.md) | [138](/filings/0001822492-25-000202.md) | [121 d](/filings/0001822492-26-000019.md) | [125](/filings/0001822492-26-000084.md) | [134](/filings/0001822492-26-000137.md) |
| Operating income | $m | [34.7](/filings/0001822492-24-000164.md) | [4.3 d](/filings/0001822492-26-000019.md) | [16.3](/filings/0001822492-25-000095.md) | [31.6](/filings/0001822492-25-000172.md) | [26.9](/filings/0001822492-25-000202.md) | [14.0 d](/filings/0001822492-26-000019.md) | [15.0](/filings/0001822492-26-000084.md) | [36.3](/filings/0001822492-26-000137.md) | [45.9](/filings/0001822492-25-000202.md) | [16.7 d](/filings/0001822492-26-000019.md) | [7.2](/filings/0001822492-26-000084.md) | [40.9](/filings/0001822492-26-000137.md) |
| Income tax | $m | [13.0](/filings/0001822492-24-000164.md) | [(1.1) d](/filings/0001822492-26-000019.md) | [(0.5)](/filings/0001822492-25-000095.md) | [5.1](/filings/0001822492-25-000172.md) | [4.4](/filings/0001822492-25-000202.md) | [0.3 d](/filings/0001822492-26-000019.md) | [(0.0)](/filings/0001822492-26-000084.md) | [6.6](/filings/0001822492-26-000137.md) | [8.0](/filings/0001822492-25-000202.md) | [1.7 d](/filings/0001822492-26-000019.md) | [(1.1)](/filings/0001822492-26-000084.md) | [6.8](/filings/0001822492-26-000137.md) |
| Net income | $m | [5.1](/filings/0001822492-24-000164.md) | [(10.1) d](/filings/0001822492-26-000019.md) | [(1.5)](/filings/0001822492-25-000202.md) | [12.5](/filings/0001822492-25-000202.md) | [7.4](/filings/0001822492-25-000202.md) | [(1.2) d](/filings/0001822492-26-000019.md) | [(0.3)](/filings/0001822492-26-000137.md) | [15.8](/filings/0001822492-26-000137.md) | [23.2](/filings/0001822492-25-000202.md) | [1.6 d](/filings/0001822492-26-000019.md) | [(4.7)](/filings/0001822492-26-000137.md) | [21.1](/filings/0001822492-26-000137.md) |
| Diluted EPS | $ per share | [0.03](/filings/0001822492-24-000164.md) | not reported | [(0.01)](/filings/0001822492-25-000095.md) | [0.06](/filings/0001822492-25-000172.md) | [0.04](/filings/0001822492-25-000202.md) | not reported | [0.00](/filings/0001822492-26-000084.md) | [0.08](/filings/0001822492-26-000137.md) | [0.12](/filings/0001822492-25-000202.md) | not reported | [(0.02)](/filings/0001822492-26-000084.md) | [0.11](/filings/0001822492-26-000137.md) |
| Basic EPS | $ per share | [0.03](/filings/0001822492-24-000164.md) | not reported | [(0.01)](/filings/0001822492-25-000095.md) | [0.06](/filings/0001822492-25-000172.md) | [0.04](/filings/0001822492-25-000202.md) | not reported | [0.00](/filings/0001822492-26-000084.md) | [0.08](/filings/0001822492-26-000137.md) | [0.12](/filings/0001822492-25-000202.md) | not reported | [(0.02)](/filings/0001822492-26-000084.md) | [0.11](/filings/0001822492-26-000137.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [39.3](/filings/0001822492-23-000162.md) | [38.6](/filings/0001822492-25-000050.md) | [30.7](/filings/0001822492-24-000087.md) | [54.0](/filings/0001822492-24-000140.md) | [59.8](/filings/0001822492-24-000164.md) | [44.5](/filings/0001822492-26-000019.md) | [36.3](/filings/0001822492-25-000095.md) | [34.2](/filings/0001822492-25-000172.md) | [37.7](/filings/0001822492-25-000202.md) | [27.3](/filings/0001822492-26-000137.md) | [27.7](/filings/0001822492-26-000084.md) | [35.8](/filings/0001822492-26-000137.md) |
| Current assets | $m | [596](/filings/0001822492-23-000162.md) | [548](/filings/0001822492-25-000050.md) | [587](/filings/0001822492-24-000087.md) | [618](/filings/0001822492-24-000140.md) | [624](/filings/0001822492-24-000164.md) | [573](/filings/0001822492-26-000019.md) | [584](/filings/0001822492-25-000095.md) | [624](/filings/0001822492-25-000172.md) | [671](/filings/0001822492-25-000202.md) | [646](/filings/0001822492-26-000137.md) | [670](/filings/0001822492-26-000084.md) | [670](/filings/0001822492-26-000137.md) |
| Total assets | $m | [2,412](/filings/0001822492-23-000162.md) | [2,331](/filings/0001822492-25-000050.md) | [2,366](/filings/0001822492-24-000087.md) | [2,385](/filings/0001822492-24-000140.md) | [2,398](/filings/0001822492-24-000164.md) | [2,331](/filings/0001822492-26-000019.md) | [2,331](/filings/0001822492-25-000095.md) | [2,357](/filings/0001822492-25-000172.md) | [2,397](/filings/0001822492-25-000202.md) | [2,356](/filings/0001822492-26-000137.md) | [2,361](/filings/0001822492-26-000084.md) | [2,376](/filings/0001822492-26-000137.md) |
| Current liabilities | $m | [233](/filings/0001822492-23-000162.md) | [223](/filings/0001822492-25-000050.md) | [236](/filings/0001822492-24-000087.md) | [267](/filings/0001822492-24-000140.md) | [269](/filings/0001822492-24-000164.md) | [254](/filings/0001822492-26-000019.md) | [237](/filings/0001822492-25-000095.md) | [273](/filings/0001822492-25-000172.md) | [273](/filings/0001822492-25-000202.md) | [258](/filings/0001822492-26-000137.md) | [227](/filings/0001822492-26-000084.md) | [247](/filings/0001822492-26-000137.md) |
| Total liabilities | $m | [1,252](/filings/0001822492-23-000162.md) | [1,177](/filings/0001822492-25-000050.md) | [1,205](/filings/0001822492-24-000087.md) | [1,211](/filings/0001822492-24-000140.md) | [1,216](/filings/0001822492-24-000164.md) | [1,148](/filings/0001822492-26-000019.md) | [1,149](/filings/0001822492-25-000095.md) | [1,150](/filings/0001822492-25-000172.md) | [1,167](/filings/0001822492-25-000202.md) | [1,128](/filings/0001822492-26-000137.md) | [1,145](/filings/0001822492-26-000084.md) | [1,151](/filings/0001822492-26-000137.md) |
| Long-term debt | $m | [780](/filings/0001822492-23-000162.md) | [732](/filings/0001822492-25-000050.md) | [751](/filings/0001822492-24-000087.md) | [732](/filings/0001822492-24-000140.md) | [731](/filings/0001822492-24-000164.md) | [692](/filings/0001822492-26-000019.md) | [713](/filings/0001822492-25-000095.md) | [683](/filings/0001822492-25-000172.md) | [683](/filings/0001822492-25-000202.md) | [668](/filings/0001822492-26-000137.md) | [714](/filings/0001822492-26-000084.md) | [678](/filings/0001822492-26-000137.md) |
| Shareholders' equity | $m | [1,160](/filings/0001822492-24-000164.md) | [1,155](/filings/0001822492-26-000019.md) | [1,161](/filings/0001822492-25-000202.md) | [1,174](/filings/0001822492-25-000202.md) | [1,181](/filings/0001822492-25-000202.md) | [1,182](/filings/0001822492-26-000137.md) | [1,182](/filings/0001822492-26-000137.md) | [1,207](/filings/0001822492-26-000137.md) | [1,230](/filings/0001822492-25-000202.md) | [1,229](/filings/0001822492-26-000137.md) | [1,216](/filings/0001822492-26-000137.md) | [1,225](/filings/0001822492-26-000137.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [56.4 d](/filings/0001822492-24-000164.md) | [66.6 d](/filings/0001822492-26-000019.md) | [11.7](/filings/0001822492-25-000095.md) | [64.8 d](/filings/0001822492-25-000172.md) | [63.7 d](/filings/0001822492-25-000202.md) | [43.1 d](/filings/0001822492-26-000019.md) | [(0.7)](/filings/0001822492-26-000084.md) | [48.7 d](/filings/0001822492-26-000137.md) | [26.2 d](/filings/0001822492-25-000202.md) | [30.9 d](/filings/0001822492-26-000019.md) | [(19.5)](/filings/0001822492-26-000084.md) | [88.0 d](/filings/0001822492-26-000137.md) |
| Capital expenditure | $m | [15.1 d](/filings/0001822492-24-000164.md) | [13.6 d](/filings/0001822492-26-000019.md) | [17.8](/filings/0001822492-25-000095.md) | [22.3 d](/filings/0001822492-25-000172.md) | [24.1 d](/filings/0001822492-25-000202.md) | [21.0 d](/filings/0001822492-26-000019.md) | [20.7](/filings/0001822492-26-000084.md) | [17.5 d](/filings/0001822492-26-000137.md) | [17.2 d](/filings/0001822492-25-000202.md) | [14.8 d](/filings/0001822492-26-000019.md) | [14.8](/filings/0001822492-26-000084.md) | [17.8 d](/filings/0001822492-26-000137.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001822492-26-000019.md) | [0.0](/filings/0001822492-26-000084.md) | [0.0 d](/filings/0001822492-26-000137.md) | [3.2 d](/filings/0001822492-25-000202.md) | [9.3 d](/filings/0001822492-26-000019.md) | [10.1](/filings/0001822492-26-000084.md) | [13.3 d](/filings/0001822492-26-000137.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-24) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [194](/filings/0001822492-23-000162.md) | [195](/filings/0001822492-24-000087.md) | [196](/filings/0001822492-24-000140.md) | [197](/filings/0001822492-24-000164.md) | [195](/filings/0001822492-25-000095.md) | [198](/filings/0001822492-25-000172.md) | [199](/filings/0001822492-25-000202.md) | [197](/filings/0001822492-26-000084.md) | [199](/filings/0001822492-26-000137.md) | [200](/filings/0001822492-25-000202.md) | [197](/filings/0001822492-26-000084.md) | [197](/filings/0001822492-26-000137.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 194,544,999 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001822492-26-000137.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.